11/19
04:45 pm
zvsa
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/19
04:20 pm
zvsa
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
Medium
Report
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
9/10
08:23 am
zvsa
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes [Yahoo! Finance]
High
Report
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes [Yahoo! Finance]
9/10
07:55 am
zvsa
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
High
Report
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes